SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the crypto community discusses its price action and potential catalysts, including speculation around XRP ETFs and regulatory clarity. Community members are debating whether XRP can break through resistance levels and reach previous highs. Some investors are also discussing Ripple's recent acquisition and its impact on XRP's long-term value.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

Floki is trending as community members celebrate its listing on Robinhood, anticipating a significant price surge. The community is actively discussing accumulation strategies, potential for high returns, and comparing Floki's potential to previous meme coin successes like Dogecoin. Some users are also highlighting Floki's utility and ongoing development efforts as reasons for optimism.

The $ROSIE project centers around a unique, AI-powered memecoin inspired by "Rosie the Robot," a beloved character known for her role as a caring, motherly robot in popular culture. The purpose of $ROSIE is twofold: entertainment through an interactive AI feature and social impact via charitable donations.  Users can interact with an AI version of Rosie on the project’s website, where they can ask questions and engage in conversations. The utility of $ROSIE goes beyond typical memecoins by enabling users to donate tokens, which will be directed towards charitable causes supporting mothers. Through this initiative, the project combines the viral appeal of meme tokens with meaningful contributions to social causes, while leveraging AI technology to create a novel user experience.

Rosie the Robot

ROSIE is trending as community members highlight its integration with Phantom Wallet and potential for significant upward movement. The cryptocurrency is generating excitement, with many anticipating a breakout. Discussions suggest strong momentum and a potentially favorable setup within the Solana ecosystem.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

The crypto token SLAP is gaining attention due to its strong community, real-world partnerships including sponsored athletes, and recent success with Team SLAP pro MMA fighter Karolina Arm. Community members highlight it's more than just a meme, but a lifestyle, actively promoting the token's unique branding and partnerships. With mentions alongside major cryptocurrencies and growing mindshare, SLAP is capturing the attention of the crypto community.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

SNDX is trending due to an FDA approval for its leukemia drug Revuforj, though a boxed warning about potential side effects has tempered initial enthusiasm. The community is weighing the drug's benefits against safety concerns, with some seeing a buying opportunity amidst the volatility and a potential buyout target. Discussions also involve comparisons to competitor KURA, especially regarding safety profiles.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings is trending as traders discuss its potential for a significant run, citing its small float and high insider ownership. Community members are drawing comparisons to past high-flying stocks and anticipating a strong opening. Bullish sentiment seems to be fueled by news, with some cautioning about potential pullbacks.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending as traders discuss its recent volatility and a company statement addressing the stock's movement; the community is weighing the potential for a rebound against concerns about dilution and market manipulation. Bullish investors are encouraged by the after-hours activity and the company's position in the artificial heart market, while others remain skeptical about its long-term prospects.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a surge in price and volume, potentially fueled by recent insider buying and milestone payments from Merck related to their Alzheimer's program. The community is actively discussing the stock's low float and the potential for a short squeeze, with some traders speculating about a run to double digits. However, some traders also caution about potential dilution.

An AI x Metaverse Protocol that is building the future of virtual interactions.

Virtual Protocol

Virtual Protocol is trending due to its focus on AI agents and recent listing on multiple exchanges, sparking increased attention. Community members are actively discussing its potential within the AI and metaverse space, with some drawing comparisons to past crypto successes. Despite some volatility, the overall sentiment remains bullish, with many anticipating significant long-term growth.

MaxsMaking, Inc. is a holding company, which engages in the manufacture of customized consumer goods. It offers a range of customizable textile products, including backpacks, thermal bags, canvas bags, aprons, throw pillows, flags, and advertising chair covers. The company was founded by Xiao Zhong Lin and Xue Fen Zhang in January 2007 and is headquartered in Shanghai, China.

MaxsMaking Inc. - Ordinary Shares - Class A

MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking (MAMK) is trending due to discussions around its low float and potential for volatility, with some traders comparing it to other recent runners. Community members are actively discussing trading strategies, potential price movements, and halt patterns, while also noting the company's business in textiles manufacturing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval

STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.

STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation

Stereotaxis partners with CardioFocus to commercialize the first robotic Pulsed Field Ablation system, aiming to revolutionize cardiac arrhythmia treatment.

STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System

Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.

STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep

Stereotaxis debuts MAGiC Sweep, the first U.S. robotic HD mapping catheter, marking a breakthrough in cardiac arrhythmia diagnosis and treatment.

ISRG's SP Stapler: A Game Changer for Colorectal and Thoracic Procedures?

Intuitive Surgical's new SP stapler opens doors to colorectal and thoracic surgeries, potentially transforming the single-port platform's adoption curve.

Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates

Stereotaxis (STXS) delivered earnings and revenue surprises of +28.57% and +10.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know

Stereotaxis (STXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Teleflex (TFX) Q2 Earnings and Revenues Top Estimates

Teleflex (TFX) delivered earnings and revenue surprises of +11.01% and +1.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial

STXS posts first peer-reviewed results for its MAGiC catheter, showing 94% efficacy and strong safety in arrhythmia treatment.

Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

Stereotaxis Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.06	--	--	N/A
Q2 '25	-$0.06	-$0.05	23.08%	BEAT
Q1 '25	-$0.07	-$0.07	3.45%	BEAT
Q4 '24	-$0.06	-$0.09	-38.46%	MISSED
Q3 '24	-$0.05	-$0.08	-52.38%	MISSED

STXS
Stereotaxis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest STXS News

STXSStereotaxis Inc